Works matching IS 00778923 AND DT 2011 AND VI 1222 AND IP 1
Results: 14
Linezolid, the first oxazolidinone antibacterial agent.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 49, doi. 10.1111/j.1749-6632.2011.05962.x
- By:
- Publication type:
- Article
Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 19, doi. 10.1111/j.1749-6632.2011.05973.x
- By:
- Publication type:
- Article
Foreword by Ban Ki-moon.
- Published in:
- 2011
- By:
- Publication type:
- Other
Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 40, doi. 10.1111/j.1749-6632.2011.05961.x
- By:
- Publication type:
- Article
Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 83, doi. 10.1111/j.1749-6632.2011.05972.x
- By:
- Publication type:
- Article
Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 90, doi. 10.1111/j.1749-6632.2011.05960.x
- By:
- Publication type:
- Article
The discovery and development of rivaroxaban.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 64, doi. 10.1111/j.1749-6632.2011.05971.x
- By:
- Publication type:
- Article
Advances in the diagnosis of respiratory tract infections: role of the Luminex xTAG respiratory viral panel.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 6, doi. 10.1111/j.1749-6632.2011.05964.x
- By:
- Publication type:
- Article
The development of romiplostim for patients with immune thrombocytopenia.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 55, doi. 10.1111/j.1749-6632.2011.05975.x
- By:
- Publication type:
- Article
Prix Galien Pro Bono Humanitarian Award Winner: Philippe Douste-Blazy.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 1, doi. 10.1111/j.1749-6632.2011.05997.x
- By:
- Publication type:
- Article
Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 14, doi. 10.1111/j.1749-6632.2011.05970.x
- By:
- Publication type:
- Article
Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 30, doi. 10.1111/j.1749-6632.2011.05963.x
- By:
- Publication type:
- Article
A review of the history, properties, and use of the immunomodulatory compound lenalidomide.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 76, doi. 10.1111/j.1749-6632.2011.05974.x
- By:
- Publication type:
- Article
Prix Galien Pro Bono Humanitarian Award Winner: William J. Clinton.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 3, doi. 10.1111/j.1749-6632.2011.05996.x
- By:
- Publication type:
- Article